Centaurus Financial’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,267
Closed -$236K 932
2022
Q1
$236K Sell
3,267
-92
-3% -$6.63K 0.02% 618
2021
Q4
$308K Sell
3,359
-162
-5% -$19.4K 0.02% 563
2021
Q3
$446K Sell
3,521
-407
-10% -$59.3K 0.04% 444
2021
Q2
$653K Buy
3,928
+494
+14% +$80K 0.06% 356
2021
Q1
$624K Sell
3,434
-1,039
-23% -$241K 0.06% 323
2020
Q4
$894K Buy
4,473
+3,109
+228% +$632K 0.09% 250
2020
Q3
$299K Buy
1,364
+203
+17% +$43K 0.04% 376
2020
Q2
$222K Sell
1,161
-125
-10% -$21.9K 0.03% 406
2020
Q1
$199K Sell
1,286
-284
-18% -$33K 0.04% 340
2019
Q4
$131K Buy
+1,570
New +$119K 0.02% 550
2019
Q3
Sell
-1,570
Closed -$104K 573
2019
Q2
$104K Sell
1,570
-14,564
-90% -$849K 0.02% 570
2019
Q1
$897K Buy
+16,134
New +$985K 0.15% 170
2018
Q4
Sell
-1,000
Closed -$112K 537
2018
Q3
$112K Sell
1,000
-200
-17% -$14.3K 0.02% 498
2018
Q2
$70K Buy
+1,200
New +$58.6K 0.01% 828

Other funds holding TDOC

Centaurus Financial's TDOC Position: Q2 2022 in Review

Centaurus Financial sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,267 shares — an estimated $236K sold.

Centaurus Financial first reported a position in TDOC in Q2 2018 and held it in 14 quarters. The position peaked at $897K in Q1 2019. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Centaurus Financial reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Centaurus Financial sold 3,267 Teladoc Health shares in Q2 2022, an estimated $236K.
  • Centaurus Financial first reported a position in Teladoc Health in Q2 2018 and held it in 14 quarters.
  • Centaurus Financial's Teladoc Health position peaked at $897K in Q1 2019.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Centaurus Financial's 13F filing for Q2 2022, filed 2 Aug 2022.